Here are four things to know.
1. Levetiracetam is intended to treat partial onset seizures related to epilepsy.
2. The tablets are a generic equivalent to UCB’s brand name drug Keppra XR.
3. Sales of sales Keppra XR and all other generic equivalents already on the market in the U.S. reached about $168 million for the 12 months ended December 2015, according to Symphony Health Solutions.
4. Intellipharmaceutics has eight other new drug applications pending FDA review.
More articles on supply chain:
6 must-reads for supply chain leaders this week
UPS to offer Saturday ground delivery services
FDA approves new liquid drug for hypothyroidism
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
